questionsmedicales.fr
Cellules
Cellules cultivées
Cellules cancéreuses en culture
Lignée cellulaire tumorale
Cellules THP-1
Cellules THP-1 : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Lignées cellulaires
Monocytes
Cytométrie en flux
Immunofluorescence
Contamination cellulaire
Mycoplasmes
Sensibilité aux médicaments
Pharmacologie
Symptômes
5
Marqueurs cellulaires
Activation cellulaire
Différenciation cellulaire
Macrophages
Prévention
5
Prévention de la contamination
Techniques aseptiques
Conditions de culture
Milieu de culture
Soins cellulaires
Stress cellulaire
Viabilité cellulaire
Congélation
Cryogénisation
Conservation cellulaire
Traitements
5
Recherche biomédicale
Médicaments
Modification génétique
CRISPR
Traitements anti-inflammatoires
Anticancéreux
Toxicité
Composés chimiques
Modélisation des maladies
Maladies inflammatoires
Complications
5
Complications expérimentales
Biais
Réponses immunitaires
Immunité
Risques de laboratoire
Contamination croisée
Agents externes
Fonction cellulaire
Minimisation des risques
Contrôles de qualité
Facteurs de risque
5
Facteurs de croissance
Milieu de culture
Agents environnementaux
Sensibilité cellulaire
Stress oxydatif
Viabilité cellulaire
Facteurs génétiques
Réponse immunitaire
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Cellules THP-1 : Questions médicales les plus fréquentes",
"headline": "Cellules THP-1 : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Cellules THP-1 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-26",
"dateModified": "2025-03-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Cellules THP-1"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Lignée cellulaire tumorale",
"url": "https://questionsmedicales.fr/mesh/D045744",
"about": {
"@type": "MedicalCondition",
"name": "Lignée cellulaire tumorale",
"code": {
"@type": "MedicalCode",
"code": "D045744",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.251.860.180"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Cellules THP-1",
"alternateName": "THP-1 Cells",
"code": {
"@type": "MedicalCode",
"code": "D000074084",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Terumasa Ikeda",
"url": "https://questionsmedicales.fr/author/Terumasa%20Ikeda",
"affiliation": {
"@type": "Organization",
"name": "2 Institute for Molecular Virology, Minneapolis, MN 55455, USA."
}
},
{
"@type": "Person",
"name": "Michael A Carpenter",
"url": "https://questionsmedicales.fr/author/Michael%20A%20Carpenter",
"affiliation": {
"@type": "Organization",
"name": "3 Center for Genome Engineering, Minneapolis, MN 55455, USA."
}
},
{
"@type": "Person",
"name": "William L Brown",
"url": "https://questionsmedicales.fr/author/William%20L%20Brown",
"affiliation": {
"@type": "Organization",
"name": "4 Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA."
}
},
{
"@type": "Person",
"name": "Reuben S Harris",
"url": "https://questionsmedicales.fr/author/Reuben%20S%20Harris",
"affiliation": {
"@type": "Organization",
"name": "3 Center for Genome Engineering, Minneapolis, MN 55455, USA."
}
},
{
"@type": "Person",
"name": "Valentina Galbiati",
"url": "https://questionsmedicales.fr/author/Valentina%20Galbiati",
"affiliation": {
"@type": "Organization",
"name": "Università Degli Studi di Milano, Laboratory of Toxicology, Dipartimento di Scienze Politiche ed Ambientali, Milan, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms.",
"datePublished": "2023-05-16",
"url": "https://questionsmedicales.fr/article/37194281",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/0284186X.2023.2212411"
}
},
{
"@type": "ScholarlyArticle",
"name": "Lung neuroendocrine neoplasms: a single centre surgical series and analysis of staging.",
"datePublished": "2023-04-27",
"url": "https://questionsmedicales.fr/article/37106553",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/ans.18493"
}
},
{
"@type": "ScholarlyArticle",
"name": "Neuroendocrine neoplasms of the lung and gastrointestinal system: convergent biology and a path to better therapies.",
"datePublished": "2022-10-28",
"url": "https://questionsmedicales.fr/article/36307533",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41571-022-00696-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Role of Bone Metastases in Lung Neuroendocrine Neoplasms: Clinical Presentation, Treatment and Impact on Prognosis.",
"datePublished": "2024-08-17",
"url": "https://questionsmedicales.fr/article/39201642",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms25168957"
}
},
{
"@type": "ScholarlyArticle",
"name": "Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms.",
"datePublished": "2024-05-02",
"url": "https://questionsmedicales.fr/article/38693435",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00262-024-03704-7"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Cellules",
"item": "https://questionsmedicales.fr/mesh/D002477"
},
{
"@type": "ListItem",
"position": 3,
"name": "Cellules cultivées",
"item": "https://questionsmedicales.fr/mesh/D002478"
},
{
"@type": "ListItem",
"position": 4,
"name": "Cellules cancéreuses en culture",
"item": "https://questionsmedicales.fr/mesh/D014407"
},
{
"@type": "ListItem",
"position": 5,
"name": "Lignée cellulaire tumorale",
"item": "https://questionsmedicales.fr/mesh/D045744"
},
{
"@type": "ListItem",
"position": 6,
"name": "Cellules THP-1",
"item": "https://questionsmedicales.fr/mesh/D000074084"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Cellules THP-1 - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Cellules THP-1",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-04-29",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Cellules THP-1",
"description": "Comment identifier les cellules THP-1 en laboratoire ?\nQuels tests sont utilisés pour caractériser les cellules THP-1 ?\nLes cellules THP-1 peuvent-elles être contaminées ?\nQuelle est la source des cellules THP-1 ?\nLes cellules THP-1 sont-elles sensibles à des médicaments ?",
"url": "https://questionsmedicales.fr/mesh/D000074084?mesh_terms=Lung+Neoplasms#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Cellules THP-1",
"description": "Quels sont les marqueurs d'activation des cellules THP-1 ?\nLes cellules THP-1 montrent-elles des signes d'inflammation ?\nComment les cellules THP-1 réagissent-elles aux pathogènes ?\nLes cellules THP-1 peuvent-elles se différencier ?\nQuels effets ont les cytokines sur les cellules THP-1 ?",
"url": "https://questionsmedicales.fr/mesh/D000074084?mesh_terms=Lung+Neoplasms#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Cellules THP-1",
"description": "Comment prévenir la contamination des cellules THP-1 ?\nQuelles conditions de culture sont idéales pour les cellules THP-1 ?\nLes cellules THP-1 nécessitent-elles des soins particuliers ?\nComment assurer la viabilité des cellules THP-1 ?\nLes cellules THP-1 peuvent-elles être cryogénisées ?",
"url": "https://questionsmedicales.fr/mesh/D000074084?mesh_terms=Lung+Neoplasms#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Cellules THP-1",
"description": "Comment les cellules THP-1 sont-elles utilisées en recherche ?\nPeut-on modifier génétiquement les cellules THP-1 ?\nQuels traitements sont testés sur les cellules THP-1 ?\nLes cellules THP-1 peuvent-elles être utilisées pour des tests de toxicité ?\nComment les cellules THP-1 aident-elles à comprendre les maladies ?",
"url": "https://questionsmedicales.fr/mesh/D000074084?mesh_terms=Lung+Neoplasms#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Cellules THP-1",
"description": "Quelles complications peuvent survenir lors de l'utilisation des cellules THP-1 ?\nLes cellules THP-1 peuvent-elles induire des réponses immunitaires indésirables ?\nQuels risques sont associés à la manipulation des cellules THP-1 ?\nLes cellules THP-1 peuvent-elles être affectées par des agents externes ?\nComment minimiser les complications lors des expériences avec THP-1 ?",
"url": "https://questionsmedicales.fr/mesh/D000074084?mesh_terms=Lung+Neoplasms#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Cellules THP-1",
"description": "Quels facteurs influencent la croissance des cellules THP-1 ?\nLes cellules THP-1 sont-elles sensibles à des agents environnementaux ?\nQuels traitements peuvent affecter les cellules THP-1 ?\nLes cellules THP-1 sont-elles affectées par le stress oxydatif ?\nQuels facteurs génétiques influencent les cellules THP-1 ?",
"url": "https://questionsmedicales.fr/mesh/D000074084?mesh_terms=Lung+Neoplasms#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier les cellules THP-1 en laboratoire ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les cellules THP-1 sont identifiées par leur morphologie et leur expression de marqueurs spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour caractériser les cellules THP-1 ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme la cytométrie en flux et l'immunofluorescence sont utilisés."
}
},
{
"@type": "Question",
"name": "Les cellules THP-1 peuvent-elles être contaminées ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, comme toutes les lignées cellulaires, elles peuvent être contaminées par des bactéries ou des mycoplasmes."
}
},
{
"@type": "Question",
"name": "Quelle est la source des cellules THP-1 ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les cellules THP-1 proviennent de la moelle osseuse d'un patient atteint de leucémie."
}
},
{
"@type": "Question",
"name": "Les cellules THP-1 sont-elles sensibles à des médicaments ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont souvent utilisées pour tester la sensibilité à divers agents pharmacologiques."
}
},
{
"@type": "Question",
"name": "Quels sont les marqueurs d'activation des cellules THP-1 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les marqueurs incluent CD14, CD11b et CD68, indiquant leur activation."
}
},
{
"@type": "Question",
"name": "Les cellules THP-1 montrent-elles des signes d'inflammation ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles produisent des cytokines pro-inflammatoires lorsqu'elles sont activées."
}
},
{
"@type": "Question",
"name": "Comment les cellules THP-1 réagissent-elles aux pathogènes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles phagocytent les pathogènes et sécrètent des médiateurs inflammatoires."
}
},
{
"@type": "Question",
"name": "Les cellules THP-1 peuvent-elles se différencier ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent se différencier en macrophages sous l'influence de certains facteurs."
}
},
{
"@type": "Question",
"name": "Quels effets ont les cytokines sur les cellules THP-1 ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les cytokines modulent leur activation et leur capacité à produire d'autres médiateurs."
}
},
{
"@type": "Question",
"name": "Comment prévenir la contamination des cellules THP-1 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des techniques aseptiques et vérifier régulièrement la pureté cellulaire."
}
},
{
"@type": "Question",
"name": "Quelles conditions de culture sont idéales pour les cellules THP-1 ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles nécessitent un milieu riche en nutriments et une température contrôlée."
}
},
{
"@type": "Question",
"name": "Les cellules THP-1 nécessitent-elles des soins particuliers ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles doivent être manipulées avec précaution pour éviter le stress cellulaire."
}
},
{
"@type": "Question",
"name": "Comment assurer la viabilité des cellules THP-1 ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir des conditions optimales de culture et éviter les cycles de congélation-décongélation."
}
},
{
"@type": "Question",
"name": "Les cellules THP-1 peuvent-elles être cryogénisées ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être cryogénisées pour une conservation à long terme."
}
},
{
"@type": "Question",
"name": "Comment les cellules THP-1 sont-elles utilisées en recherche ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont utilisées pour étudier les mécanismes immunitaires et tester des médicaments."
}
},
{
"@type": "Question",
"name": "Peut-on modifier génétiquement les cellules THP-1 ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des techniques comme CRISPR peuvent être utilisées pour modifier leur génome."
}
},
{
"@type": "Question",
"name": "Quels traitements sont testés sur les cellules THP-1 ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements anti-inflammatoires et anticancéreux sont souvent testés."
}
},
{
"@type": "Question",
"name": "Les cellules THP-1 peuvent-elles être utilisées pour des tests de toxicité ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont souvent utilisées pour évaluer la toxicité des composés chimiques."
}
},
{
"@type": "Question",
"name": "Comment les cellules THP-1 aident-elles à comprendre les maladies ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles modélisent des maladies inflammatoires et infectieuses pour étudier les mécanismes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir lors de l'utilisation des cellules THP-1 ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des résultats biaisés peuvent survenir si les cellules sont contaminées ou mal caractérisées."
}
},
{
"@type": "Question",
"name": "Les cellules THP-1 peuvent-elles induire des réponses immunitaires indésirables ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent parfois produire des réponses immunitaires non spécifiques."
}
},
{
"@type": "Question",
"name": "Quels risques sont associés à la manipulation des cellules THP-1 ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le risque principal est la contamination croisée avec d'autres lignées cellulaires."
}
},
{
"@type": "Question",
"name": "Les cellules THP-1 peuvent-elles être affectées par des agents externes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des agents comme les toxines ou les médicaments peuvent altérer leur fonction."
}
},
{
"@type": "Question",
"name": "Comment minimiser les complications lors des expériences avec THP-1 ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Suivre des protocoles stricts et effectuer des contrôles réguliers de qualité."
}
},
{
"@type": "Question",
"name": "Quels facteurs influencent la croissance des cellules THP-1 ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme la température, le pH et la composition du milieu influencent leur croissance."
}
},
{
"@type": "Question",
"name": "Les cellules THP-1 sont-elles sensibles à des agents environnementaux ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être affectées par des agents chimiques ou physiques dans leur environnement."
}
},
{
"@type": "Question",
"name": "Quels traitements peuvent affecter les cellules THP-1 ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements comme les cytokines ou les médicaments peuvent moduler leur activité."
}
},
{
"@type": "Question",
"name": "Les cellules THP-1 sont-elles affectées par le stress oxydatif ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress oxydatif peut altérer leur fonction et leur viabilité."
}
},
{
"@type": "Question",
"name": "Quels facteurs génétiques influencent les cellules THP-1 ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des variations génétiques peuvent affecter leur réponse aux stimuli immunitaires."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 21/03/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
2 Institute for Molecular Virology, Minneapolis, MN 55455, USA.
3 Center for Genome Engineering, Minneapolis, MN 55455, USA.
5 Howard Hughes Medical Institute, University of Minnesota, Minneapolis, MN 55455, USA.
1 Department of Biochemistry, Molecular Biology, and Biophysics, Minneapolis, MN 55455, USA.
4 Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
Publications dans "Cellules THP-1" :
3 publications dans cette catégorie
Affiliations :
3 Center for Genome Engineering, Minneapolis, MN 55455, USA.
1 Department of Biochemistry, Molecular Biology, and Biophysics, Minneapolis, MN 55455, USA.
4 Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
2 Institute for Molecular Virology, Minneapolis, MN 55455, USA.
5 Howard Hughes Medical Institute, University of Minnesota, Minneapolis, MN 55455, USA.
Publications dans "Cellules THP-1" :
3 publications dans cette catégorie
Affiliations :
4 Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
3 Center for Genome Engineering, Minneapolis, MN 55455, USA.
2 Institute for Molecular Virology, Minneapolis, MN 55455, USA.
1 Department of Biochemistry, Molecular Biology, and Biophysics, Minneapolis, MN 55455, USA.
Publications dans "Cellules THP-1" :
3 publications dans cette catégorie
Affiliations :
3 Center for Genome Engineering, Minneapolis, MN 55455, USA.
1 Department of Biochemistry, Molecular Biology, and Biophysics, Minneapolis, MN 55455, USA.
4 Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
2 Institute for Molecular Virology, Minneapolis, MN 55455, USA.
5 Howard Hughes Medical Institute, University of Minnesota, Minneapolis, MN 55455, USA.
Publications dans "Cellules THP-1" :
3 publications dans cette catégorie
Affiliations :
Università Degli Studi di Milano, Laboratory of Toxicology, Dipartimento di Scienze Politiche ed Ambientali, Milan, Italy.
Publications dans "Cellules THP-1" :
3 publications dans cette catégorie
Affiliations :
Università Degli Studi di Milano, Laboratory of Toxicology, Dipartimento di Scienze Politiche ed Ambientali, Milan, Italy.
Publications dans "Cellules THP-1" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of The Ministry of Education for Conservation and Utilization of Special Biological Resources in The West, Yinchuan, Ningxia 750021, P.R. China.
College of Life Science, Ningxia University, Yinchuan, Ningxia 750021, P.R. China.
Publications dans "Cellules THP-1" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of The Ministry of Education for Conservation and Utilization of Special Biological Resources in The West, Yinchuan, Ningxia 750021, P.R. China.
College of Life Science, Ningxia University, Yinchuan, Ningxia 750021, P.R. China.
Publications dans "Cellules THP-1" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of The Ministry of Education for Conservation and Utilization of Special Biological Resources in The West, Yinchuan, Ningxia 750021, P.R. China.
College of Life Science, Ningxia University, Yinchuan, Ningxia 750021, P.R. China.
Publications dans "Cellules THP-1" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of The Ministry of Education for Conservation and Utilization of Special Biological Resources in The West, Yinchuan, Ningxia 750021, P.R. China.
College of Life Science, Ningxia University, Yinchuan, Ningxia 750021, P.R. China.
Publications dans "Cellules THP-1" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of The Ministry of Education for Conservation and Utilization of Special Biological Resources in The West, Yinchuan, Ningxia 750021, P.R. China.
College of Life Science, Ningxia University, Yinchuan, Ningxia 750021, P.R. China.
Publications dans "Cellules THP-1" :
2 publications dans cette catégorie
Affiliations :
Cheeloo College of Medicine, Shandong University Ji'nan 250012, China.
Publications dans "Cellules THP-1" :
2 publications dans cette catégorie
Affiliations :
Università Degli Studi di Pavia, Dipartimento di Scienze del Farmaco, Pavia, Italy.
Publications dans "Cellules THP-1" :
2 publications dans cette catégorie
Affiliations :
Università Degli Studi di Pavia, Dipartimento di Scienze del Farmaco, Pavia, Italy.
Scuola Universitaria Superiore IUSS, Pavia, Italy.
Publications dans "Cellules THP-1" :
2 publications dans cette catégorie
Affiliations :
Università Degli Studi di Pavia, Dipartimento di Scienze del Farmaco, Pavia, Italy.
Publications dans "Cellules THP-1" :
2 publications dans cette catégorie
Affiliations :
Università Degli Studi di Pavia, Dipartimento di Scienze del Farmaco, Pavia, Italy.
Publications dans "Cellules THP-1" :
2 publications dans cette catégorie
Affiliations :
University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia.
Publications dans "Cellules THP-1" :
2 publications dans cette catégorie
Affiliations :
Department of Hematology, West China School of Medicine/West China Hospital, Sichuan University, Chengdu, China, 3341148215@qq.com.
Department of Hematology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Publications dans "Cellules THP-1" :
2 publications dans cette catégorie
Affiliations :
Department of Hematology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Publications dans "Cellules THP-1" :
2 publications dans cette catégorie
Affiliations :
Shandong Provincial Key Laboratory of Animal Resistance Biology, Institute of Biomedical Sciences, College of Life Sciences, Shandong Normal University, Jinan, Shandong 250014, P.R. China.
Publications dans "Cellules THP-1" :
Lung neuroendocrine neoplasms (NEN) are a heterogeneous population of neoplasms with different pathology, clinical behavior, and prognosis compared to the more common lung cancers. The diagnostic work...
To review the outcomes of surgically resected lung neuroendocrine neoplasms (LNEN) at a tertiary referral centre and to validate a previously published LNEN-specific staging system (NETL)....
All patients who were identified on histopathology to have LNEN were included. Pre-, intra- and post-operative outcomes were collected, including long-term survival. Patients were staged by both the T...
A total of 132 patients were included in the study, with a median age of 65 years; 55% were female. Typical carcinoid (TC) was the most common pathology (53.4%) followed by large cell neuroendocrine c...
This is the largest known Australian series of LNEN to date, showing survival comparable to international outcomes. We have demonstrated large variations in outcome, driven by histological grade. The ...
Neuroendocrine neoplasms (NENs) can develop in almost any organ and span a spectrum from well-differentiated and indolent neuroendocrine tumours (NETs) to poorly differentiated and highly aggressive n...
Lung neuroendocrine neoplasms (L-NEN) are heterogeneous tumors. While bone metastases (BM) have been associated with worse prognosis in other NEN, their role in L-NEN deserves in-depth analysis. This ...
Advancements in immunotherapeutic approaches only had a modest impact on the therapy of lung neuroendocrine neoplasms (LNENs). Our multicenter study aimed to investigate the expression patterns of nov...
The expressions of V-domain Ig suppressor of T cell activation (VISTA), OX40L, Glucocorticoid-induced TNF receptor (GITR), and T cell immunoglobulin and mucin domain 3 (TIM3) proteins were measured by...
Tumor cell TIM3 expression was the highest in ACs (p < 0.001), whereas elevated tumor cell GITR levels were characteristic for both ACs and SCLCs (p < 0.001 and p = 0.011, respectively). OX40L express...
LNEN subtypes have characteristic and widely divergent VISTA, OX40L, GITR, and TIM3 protein expressions. By shedding light on the different expression patterns of these immunotherapy targets, the curr...
Although immunotherapy has led to a paradigm shift in the treatment of lung cancer, the therapeutic approaches for lung neuroendocrine neoplasms (LNENs) are still limited. Our aim was to explore the i...
Surgically removed tumor samples of 26 atypical carcinoid (AC), 30 large cell neuroendocrine carcinoma (LCNEC) and 29 small cell lung cancer (SCLC) patients were included. The immune phenotype of each...
Unsupervised hierarchical clustering revealed distinct immunologic profiles across tumor types. Specifically, AC tumors were characterized by high tumor cell CD40 expression and low levels of immune i...
By providing insights into the widely divergent immunologic profiles of LNENs, our results might serve as a basis for the development of novel immunotherapy-related approaches in these devastating mal...
Enhanced recovery after surgery programs have reduced complications and shortened hospital stays after lung resection. This study aimed to determine whether video-assisted thoracoscopic surgery perfor...
This retrospective, propensity-matched, cohort analysis was conducted from January 2020 to August 2020. Among 959 patients who underwent video-assisted thoracoscopic surgery, 739 underwent inpatient s...
Propensity matching estimated 218 patients in each group. The mean length of hospital stay was shorter in the two-day surgery group (2.17 ± 0.89 days) than in the inpatient surgery group (6.31 ± 2.13 ...
Two-day surgery is a safe, feasible, and cost-effective procedure for selected patients with lung neoplasms when combined with accurate preoperative evaluations, successful intraoperative assessments,...
Recently, advancement of somatostatin receptor (SSTR) imaging and theragnostic approach using peptide receptor radionuclide therapy (PRRT) have changed the paradigm of diagnosis and management of neur...
Metastasis to the thyroid gland is very uncommon with an incidence of 2-3% of all thyroid malignancies. A higher incidence is noted in autopsy studies indicating incidental detection. However, tumour-...
The roles of cyclin-dependent kinase 6 (CDK6) in various cancers, including small cell lung carcinoma (SCLC), remain unclear. Here, 111,54 multi-center samples were investigated to determine the expre...